My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 718

    1.

    "The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline?.

    Jacobson TA.

    Ann Intern Med. 2000 Oct 3;133(7):549-54. Review.PMID: 11015169 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Are we aggressive enough in lowering cholesterol?

    Waters DD.

    Am J Cardiol. 2001 Aug 16;88(4A):10F-5F. Review.PMID: 11520481 [PubMed - indexed for MEDLINE]Related articles

    3.

    Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

    Evans M, Roberts A, Davies S, Rees A.

    Drugs. 2004;64(11):1181-96. Review.PMID: 15161326 [PubMed - indexed for MEDLINE]Related articles

    4.

    Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.

    Hunninghake DB.

    Am J Med. 1998 Feb 23;104(2A):9S-13S.PMID: 9550501 [PubMed - indexed for MEDLINE]Related articles

    5.

    Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.

    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.

    Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94.PMID: 17996658 [PubMed - indexed for MEDLINE]Related articles

    6.

    Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials.

    White CW.

    Am J Med. 1998 Jul 6;105(1A):63S-68S. Review.PMID: 9707270 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Statins in primary prevention of coronary heart disease]

    Paulweber B.

    Wien Med Wochenschr. 1999;149(5-6):129-38. Review. German. PMID: 10408004 [PubMed - indexed for MEDLINE]Related articles

    8.

    Managing dyslipidemia in the high-risk patient.

    Stein EA.

    Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.PMID: 11900720 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.

    Plans-Rubió P.

    Am J Cardiovasc Drugs. 2006;6(3):177-88.PMID: 16780391 [PubMed - indexed for MEDLINE]Related articles

    10.

    Low density lipoprotein cholesterol lowering: are the treatment guidelines still appropriate?

    Deslypere JP.

    Int J Clin Pract. 2000 Jun;54(5):307-13. Review.PMID: 10954957 [PubMed - indexed for MEDLINE]Related articles

    11.

    Statin trials and goals of cholesterol-lowering therapy after AMI.

    Pedersen TR.

    Am Heart J. 1999 Aug;138(2 Pt 2):S177-82. Review.PMID: 10426879 [PubMed - indexed for MEDLINE]Related articles

    12.

    Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.

    Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.

    Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C.PMID: 12646338 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease.

    Hay JW, Yu WM, Ashraf T.

    Pharmacoeconomics. 1999 Jan;15(1):47-74. Review.PMID: 10345158 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy]

    Schaefer JR, Herzum M, Maisch B.

    Herz. 1999 Feb;24(1):3-12. Review. German. PMID: 10093008 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials.

    Eisenberg DA.

    Am J Med. 1998 Feb 23;104(2A):2S-5S. Review.PMID: 9550499 [PubMed - indexed for MEDLINE]Related articles

    16.

    Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

    Daskalopoulou SS, Mikhailidis DP.

    Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.PMID: 16574035 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting.

    Gotto AM Jr, Grundy SM.

    Circulation. 1999 Mar 2;99(8):E1-7.PMID: 10051310 [PubMed - indexed for MEDLINE]Related articles

    18.

    Review of recent clinical trials of lipid lowering in coronary artery disease.

    Smith SC Jr.

    Am J Cardiol. 1997 Oct 30;80(8B):10H-13H. Review.PMID: 9372993 [PubMed - indexed for MEDLINE]Related articles

    19.

    Low-density lipoproteins and risk for coronary artery disease.

    Ballantyne CM.

    Am J Cardiol. 1998 Nov 5;82(9A):3Q-12Q. Review.PMID: 9819098 [PubMed - indexed for MEDLINE]Related articles

    20.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

    J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.PMID: 15358046 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity